Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Insomnia and its treatment].

A Prusiński1

  • 1Katedry i Kliniki Neurologii AM w Lodzi.

Neurologia I Neurochirurgia Polska
|December 7, 2000
PubMed
Summary

Insomnia affects 35% of the population and requires medical attention for chronic cases. New hypnotic drugs like cyclopyrrolones offer safer alternatives to benzodiazepines for sleep disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tolerability and efficacy of almotriptan in the long-term treatment of migraine.

European neurology·2001
Same author

[Selected problems for discussion of procedures in epilepsy].

Neurologia i neurochirurgia polska·2000
Same author

[Drug rebound headaches].

Neurologia i neurochirurgia polska·2000
Same author

[Emergency treatment of migraine attacks with particular reference to agonists of 5-HT1B/1D receptor].

Neurologia i neurochirurgia polska·2000
Same author

Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study.

Cephalalgia : an international journal of headache·2000
Same author

[Feverfew as a prophylactic treatment of migraine].

Neurologia i neurochirurgia polska·2000

Area of Science:

  • Sleep Medicine
  • Pharmacology

Context:

  • Insomnia is a prevalent sleep disorder affecting approximately 35% of the population.
  • It encompasses various issues like difficulty falling asleep, frequent awakenings, and non-restorative sleep.
  • Chronic insomnia necessitates medical intervention due to potential drug dependence and significant quality of life impairment.

Purpose:

  • To review the causes and treatment of insomnia.
  • To compare traditional hypnotics with newer agents.
  • To highlight the advantages of cyclopyrrolones in managing insomnia.

Summary:

  • Insomnia presents as difficulty initiating or maintaining sleep, or poor sleep quality, impacting a large demographic.
  • Causes range from psychological and somatic conditions to toxic factors and poor sleep hygiene.
  • Treatment focuses on addressing underlying causes and improving sleep hygiene, with pharmacotherapy reserved for short-term use.

Impact:

  • Benzodiazepines, while effective, have significant drawbacks.
  • Cyclopyrrolones (e.g., Zolpidem, Zopiclone) represent a newer class of hypnotics with improved safety profiles.
  • These newer agents exhibit shorter half-lives, reduced adverse effects, and lower dependence potential, offering a better therapeutic option for insomnia.

Related Experiment Videos